(IBTA) Ibotta - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4510511060

IBTA: Digital, Promotions, Advertising, Platform, Network

Ibotta, Inc. (NYSE:IBTA) is a digital advertising and technology firm specializing in performance-based marketing solutions. The company connects consumer packaged goods (CPG) brands with consumers through its proprietary Ibotta Performance Network (IPN), a scalable platform enabling targeted digital promotions. IPN integrates with a diverse range of digital properties, including direct-to-consumer channels like mobile apps, websites, and browser extensions, as well as third-party publisher networks. This allows brands to deliver personalized offers, coupons, and ads to users based on shopping behavior and preferences. Ibotta also offers a suite of digital advertising products, including display ads, sponsored content, and feature placements, designed to maximize return on ad spend (ROAS).

Originally founded in 2011 as Zing Enterprises, Inc., the company rebranded to Ibotta, Inc. in 2012 and has since established itself as a key player in the digital coupon and advertising space. Headquartered in Denver, Colorado, Ibotta operates a platform-agnostic model, enabling seamless integration with major retailers and publishers. Its focus on performance-based marketing aligns with the growing demand for measurable and data-driven advertising solutions.

3-Month Forecast: Based on and , Ibottas stock (IBTA) is expected to show moderate growth in the near term. The stock is trading above its 20-day SMA (46.87) and 50-day SMA (44.54) at 50.19, indicating positive momentum. However, the 200-day SMA (60.62) suggests potential resistance at higher levels. The ATR of 2.35 indicates manageable volatility. From a perspective, Ibottas P/E ratio of 18.63 reflects reasonable valuation, though the forward P/E of 45.45 signals market expectations for future earnings growth. With a market cap of $1.258 billion and a P/S ratio of 3.43, the company is well-positioned to capitalize on its strong RoE of 15.03%. Over the next three months, expect IBTA to trade within a range of $47 to $55, with potential upside driven by earnings performance and macroeconomic conditions.

Additional Sources for IBTA Stock

IBTA Stock Overview

Market Cap in USD 1,324m
Sector Technology
Industry Software - Application
GiC Sub-Industry Advertising
IPO / Inception 2024-04-18

IBTA Stock Ratings

Growth Rating -40.0
Fundamental 89.7
Dividend Rating 0.0
Rel. Strength -55.4
Analysts 3.78/5
Fair Price Momentum 37.94 USD
Fair Price DCF 55.52 USD

IBTA Dividends

No Dividends Paid

IBTA Growth Ratios

Growth Correlation 3m -2%
Growth Correlation 12m -52.2%
Growth Correlation 5y -58.8%
CAGR 5y -49.49%
CAGR/Max DD 5y -0.70
Sharpe Ratio 12m -0.21
Alpha -60.85
Beta 0.937
Volatility 60.44%
Current Volume 410.9k
Average Volume 20d 321k
What is the price of IBTA stocks?
As of May 09, 2025, the stock is trading at USD 47.78 with a total of 410,904 shares traded.
Over the past week, the price has changed by -3.46%, over one month by +11.32%, over three months by -34.11% and over the past year by -50.61%.
Is Ibotta a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Ibotta (NYSE:IBTA) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 89.72 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBTA as of May 2025 is 37.94. This means that IBTA is currently overvalued and has a potential downside of -20.59%.
Is IBTA a buy, sell or hold?
Ibotta has received a consensus analysts rating of 3.78. Therefor, it is recommend to hold IBTA.
  • Strong Buy: 2
  • Buy: 3
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
What are the forecast for IBTA stock price target?
According to ValueRays Forecast Model, IBTA Ibotta will be worth about 42.9 in May 2026. The stock is currently trading at 47.78. This means that the stock has a potential downside of -10.17%.
Issuer Forecast Upside
Wallstreet Target Price 50.3 5.2%
Analysts Target Price 50.3 5.2%
ValueRay Target Price 42.9 -10.2%